Associated Papers
Case Report: Novel variants in the MYD88 gene (c.104T>C, c.141G>C) in a patient with recurrent abscesses as a cause of type 68 immunodeficiency.
Buianova AA et al.
Frontiers in Immunology, 2025
Potential associations between variants of genes encoding regulators of inflammation, and mediators of inflammation in type 2 diabetes and insulin resistance.
Ozbayer C et al.
Journal of Clinical Pharmacy and Therapeutics, 2021
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.
Weber ANR et al.
Cancer Immunology, Immunotherapy : Cii, 2018
IRAK2 is associated with susceptibility to rheumatoid arthritis.
Hassine HB et al.
Clinical Rheumatology, 2018
A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.
Wang H et al.
The Journal of Biological Chemistry, 2014
Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein.
Vajjhala PR et al.
The Journal of Biological Chemistry, 2012
Genetic variation in Toll-like receptors and disease susceptibility.
Netea MG et al.
Nature Immunology, 2012
Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
George J et al.
The Journal of Biological Chemistry, 2011
Select a paper to view details